PortfoliosLab logoPortfoliosLab logo
RCUS vs. SCHZ
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

RCUS vs. SCHZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Arcus Biosciences, Inc. (RCUS) and Schwab U.S. Aggregate Bond ETF (SCHZ). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, RCUS achieves a 0.13% return, which is significantly lower than SCHZ's 0.30% return.


RCUS

1D
-2.49%
1M
-8.41%
YTD
0.13%
6M
-6.91%
1Y
137.89%
3Y*
4.33%
5Y*
-0.97%
10Y*

SCHZ

1D
-0.17%
1M
0.26%
YTD
0.30%
6M
0.15%
1Y
5.16%
3Y*
3.94%
5Y*
0.07%
10Y*
1.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

RCUS vs. SCHZ - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
RCUS
Arcus Biosciences, Inc.
0.13%60.04%-22.04%-7.64%-48.90%55.89%157.03%-6.22%-36.65%
SCHZ
Schwab U.S. Aggregate Bond ETF
0.30%7.24%1.26%5.60%-13.17%-1.72%7.46%8.65%1.68%

Correlation

The correlation between RCUS and SCHZ is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.18

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Mar 16, 2018

0.09

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RCUS vs. SCHZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RCUS
RCUS Risk / Return Rank: 8888
Overall Rank
RCUS Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
RCUS Sortino Ratio Rank: 8585
Sortino Ratio Rank
RCUS Omega Ratio Rank: 8484
Omega Ratio Rank
RCUS Calmar Ratio Rank: 9191
Calmar Ratio Rank
RCUS Martin Ratio Rank: 9090
Martin Ratio Rank

SCHZ
SCHZ Risk / Return Rank: 3737
Overall Rank
SCHZ Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
SCHZ Sortino Ratio Rank: 3939
Sortino Ratio Rank
SCHZ Omega Ratio Rank: 3535
Omega Ratio Rank
SCHZ Calmar Ratio Rank: 3838
Calmar Ratio Rank
SCHZ Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RCUS vs. SCHZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Arcus Biosciences, Inc. (RCUS) and Schwab U.S. Aggregate Bond ETF (SCHZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RCUSSCHZDifference
Sharpe ratioReturn per unit of total volatility

+0.88

Sortino ratioReturn per unit of downside risk

+0.66

Omega ratioGain probability vs. loss probability

1.34

1.24

+0.10

Calmar ratioReturn relative to maximum drawdown

4.99

1.92

+3.07

Martin ratioReturn relative to average drawdown

12.31

5.87

+6.44

RCUS vs. SCHZ - Sharpe Ratio Comparison

The current RCUS Sharpe Ratio is 2.25, which is higher than the SCHZ Sharpe Ratio of 1.37. The chart below compares the historical Sharpe Ratios of RCUS and SCHZ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


RCUSSCHZDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.25

1.37

+0.88

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

0.01

-0.03

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.28

Sharpe Ratio (All Time)

Calculated using the full available price history

0.06

0.44

-0.38

Drawdowns

RCUS vs. SCHZ - Drawdown Comparison

The maximum RCUS drawdown since its inception was -85.83%, which is greater than SCHZ's maximum drawdown of -18.74%. Use the drawdown chart below to compare losses from any high point for RCUS and SCHZ.


Loading charts...

Drawdown Indicators


RCUSSCHZDifference

Max Drawdown

Largest peak-to-trough decline

-85.83%

-18.74%

-67.09%

Max Drawdown (1Y)

Largest decline over 1 year

-27.78%

-2.70%

-25.08%

Max Drawdown (3Y)

Largest decline over 3 years

-70.82%

-6.18%

-64.64%

Max Drawdown (5Y)

Largest decline over 5 years

-85.83%

-18.01%

-67.82%

Max Drawdown (10Y)

Largest decline over 10 years

-18.74%

Current Drawdown

Current decline from peak

-50.77%

-2.47%

-48.30%

Average Drawdown

Average peak-to-trough decline

-46.54%

-3.68%

-42.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.26%

0.88%

+10.38%

Volatility

RCUS vs. SCHZ - Volatility Comparison

Arcus Biosciences, Inc. (RCUS) has a higher volatility of 12.17% compared to Schwab U.S. Aggregate Bond ETF (SCHZ) at 1.24%. This indicates that RCUS's price experiences larger fluctuations and is considered to be riskier than SCHZ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


RCUSSCHZDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.17%

1.24%

+10.93%

Volatility (6M)

Calculated over the trailing 6-month period

46.19%

2.67%

+43.52%

Volatility (1Y)

Calculated over the trailing 1-year period

62.22%

3.79%

+58.43%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

67.12%

6.08%

+61.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

76.34%

5.41%

+70.93%

Dividends

RCUS vs. SCHZ - Dividend Comparison

RCUS has not paid dividends to shareholders, while SCHZ's dividend yield for the trailing twelve months is around 4.12%.


PositionTTM20252024202320222021202020192018201720162015
RCUS
Arcus Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SCHZ
Schwab U.S. Aggregate Bond ETF
4.12%4.05%3.96%3.28%2.63%2.16%2.43%2.79%2.56%2.40%2.24%2.11%

Frequently Asked Questions


RCUS and SCHZ have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

RCUS has higher volatility (12.17%) compared to SCHZ (1.24%). In terms of maximum drawdown, RCUS dropped -85.83% vs SCHZ's -18.74%.

RCUS currently has the higher Sharpe Ratio (2.25 vs 1.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for RCUS and SCHZ

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer